Published in Breast Cancer Res on July 07, 2000
Estrogen Regulation of MicroRNA Expression. Curr Genomics (2009) 1.20
A role for estrogen receptor phosphorylation in the resistance to tamoxifen. Int J Breast Cancer (2011) 1.02
Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor alpha. Nucleic Acids Res (2007) 1.01
Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells. Biochim Biophys Acta (2010) 0.96
Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta. Environ Health Perspect (2010) 0.94
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol (2015) 0.94
Estrogen receptors recruit SMRT and N-CoR corepressors through newly recognized contacts between the corepressor N terminus and the receptor DNA binding domain. Mol Cell Biol (2010) 0.86
A DNA repair BRCA1 estrogen receptor and targeted therapy in breast cancer. Int J Mol Sci (2012) 0.83
Versatility or promiscuity: the estrogen receptors, control of ligand selectivity and an update on subtype selective ligands. Int J Environ Res Public Health (2014) 0.81
Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha. BMC Struct Biol (2013) 0.80
Structurally similar estradiol analogs uniquely alter the regulation of intracellular signaling pathways. J Mol Endocrinol (2012) 0.78
Rational modification of estrogen receptor by combination of computational and experimental analysis. PLoS One (2014) 0.77
Computational study of evolutionary selection pressure on rainbow trout estrogen receptors. PLoS One (2010) 0.77
Rationally modified estrogen receptor protein as a bio-recognition element for the detection of EDC pollutants: strategies and opportunities. Int J Environ Res Public Health (2015) 0.75
Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha. J Mol Model (2014) 0.75
Designer interface peptide grafts target estrogen receptor alpha dimerization. Biochem Biophys Res Commun (2016) 0.75
Production of unstable proteins through the formation of stable core complexes. Nat Commun (2016) 0.75
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (1986) 11.35
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell (1998) 9.96
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 9.57
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature (1998) 8.33
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature (1991) 7.46
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell (1988) 6.59
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (1995) 5.40
Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev (1998) 5.28
Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (1995) 4.79
A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 4.69
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J (1992) 4.69
Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci U S A (1985) 4.58
The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol (1998) 3.08
The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell (1993) 2.95
Atomic structure of progesterone complexed with its receptor. Nature (1998) 2.83
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J (1999) 2.81
Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci U S A (1998) 2.68
Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol (1991) 2.54
Solution structure of the DNA-binding domain of the oestrogen receptor. Nature (1990) 2.13
Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci U S A (1990) 2.03
Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res (1998) 1.85
The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids (1997) 1.80
The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem Biophys Res Commun (1998) 1.71
The basis for half-site specificity explored through a non-cognate steroid receptor-DNA complex. Nat Struct Biol (1995) 1.40
DNA recognition by the oestrogen receptor: from solution to the crystal. Structure (1993) 1.30
Estrogen receptors: how do they control reproductive and nonreproductive functions? Biochem Biophys Res Commun (2000) 1.20
The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation. Structure (1995) 1.12
The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc Natl Acad Sci U S A (1996) 1.07
A conserved carboxy-terminal subdomain is important for ligand interpretation and transactivation by nuclear receptors. Endocrinology (1994) 1.01
Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators. J Med Chem (1998) 0.89
Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination. Mol Endocrinol (1996) 0.87
Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature (1990) 9.21
An attempt to unify the structure of polymerases. Protein Eng (1990) 7.93
Chemical and biological evolution of nucleotide-binding protein. Nature (1974) 7.39
Crystallographic refinement of yeast aspartic acid transfer RNA. J Mol Biol (1985) 6.33
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (1995) 5.40
Class II aminoacyl transfer RNA synthetases: crystal structure of yeast aspartyl-tRNA synthetase complexed with tRNA(Asp). Science (1991) 4.87
Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (1995) 4.79
A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 4.69
Correlation between segmental mobility and the location of antigenic determinants in proteins. Nature (1984) 3.66
Transmembrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes. Cell (1998) 3.27
Zinc ion mediated amino acid discrimination by threonyl-tRNA synthetase. Nat Struct Biol (2000) 2.97
The bromodomain revisited. Trends Biochem Sci (1997) 2.95
An operational RNA code for amino acids and possible relationship to genetic code. Proc Natl Acad Sci U S A (1993) 2.87
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell (2000) 2.77
The structure of threonyl-tRNA synthetase-tRNA(Thr) complex enlightens its repressor activity and reveals an essential zinc ion in the active site. Cell (1999) 2.74
Crystal structure of yeast tRNAAsp. Nature (1980) 2.61
Yeast tRNA(Asp) recognition by its cognate class II aminoacyl-tRNA synthetase. Nature (1993) 2.57
Spontaneous assembly of double-stranded helicates from oligobipyridine ligands and copper(I) cations: structure of an inorganic double helix. Proc Natl Acad Sci U S A (1987) 2.57
Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A. Proteins (2004) 2.51
Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell (2000) 2.33
Structural and functional considerations of the aminoacylation reaction. Trends Biochem Sci (1997) 2.22
Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RNA crystals. Acta Crystallogr A (1988) 2.08
Transfer RNA-mediated editing in threonyl-tRNA synthetase. The class II solution to the double discrimination problem. Cell (2000) 2.05
Studies of asymmetry in the three-dimensional structure of lobster D-glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1975) 2.05
A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell (2001) 2.02
The active site of yeast aspartyl-tRNA synthetase: structural and functional aspects of the aminoacylation reaction. EMBO J (1994) 1.99
Synthesis of aspartyl-tRNA(Asp) in Escherichia coli--a snapshot of the second step. EMBO J (1999) 1.88
tRNA aminoacylation by arginyl-tRNA synthetase: induced conformations during substrates binding. EMBO J (2000) 1.88
Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J (2000) 1.86
The aminoacyl-tRNA synthetase family: modules at work. Bioessays (1993) 1.64
D-glyceraldehyde-3-phosphate dehydrogenase: three-dimensional structure and evolutionary significance. Proc Natl Acad Sci U S A (1973) 1.64
Molecular structure of human TFIIH. Cell (2000) 1.64
Human TAF(II)28 and TAF(II)18 interact through a histone fold encoded by atypical evolutionary conserved motifs also found in the SPT3 family. Cell (1998) 1.63
Crystal structure of Aeromonas proteolytica aminopeptidase: a prototypical member of the co-catalytic zinc enzyme family. Structure (1994) 1.58
Structure determination of crystalline lobster D-glyceraldehyde-3-phosphate dehydrogenase. J Mol Biol (1974) 1.57
Structural studies on nuclear receptors. Cell Mol Life Sci (2000) 1.57
Novel NADPH-binding domain revealed by the crystal structure of aldose reductase. Nature (1992) 1.54
Crystallographic structure of an RNA helix: [U(UA)6A]2. J Mol Biol (1989) 1.53
Crystal structure of glycyl-tRNA synthetase from Thermus thermophilus. EMBO J (1995) 1.50
Comparison of the tertiary structure of yeast tRNA(Asp) and tRNA(Phe) in solution. Chemical modification study of the bases. J Mol Biol (1987) 1.50
Solution structure of a tRNA with a large variable region: yeast tRNASer. J Mol Biol (1989) 1.47
TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ (2008) 1.47
Binding of ligands and activation of transcription by nuclear receptors. Annu Rev Biophys Biomol Struct (2001) 1.46
The human TFIID components TAF(II)135 and TAF(II)20 and the yeast SAGA components ADA1 and TAF(II)68 heterodimerize to form histone-like pairs. Mol Cell Biol (2000) 1.45
Base-pairing shift in the major groove of (CA)n tracts by B-DNA crystal structures. Nature (1991) 1.42
Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center. J Biol Chem (2000) 1.42
Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP. EMBO J (1997) 1.41
The 2.0 A crystal structure of Thermus thermophilus methionyl-tRNA synthetase reveals two RNA-binding modules. Structure (2000) 1.40
Crystal structure of histidyl-tRNA synthetase from Escherichia coli complexed with histidyl-adenylate. EMBO J (1995) 1.35
The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution. Structure (1997) 1.34
Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J Mol Biol (2001) 1.33
L-arginine recognition by yeast arginyl-tRNA synthetase. EMBO J (1998) 1.33
3-D graphics modelling of the tRNA-like 3'-end of turnip yellow mosaic virus RNA: structural and functional implications. J Biomol Struct Dyn (1987) 1.33
The TBP-like factor: an alternative transcription factor in metazoa? Trends Biochem Sci (1999) 1.33
Crystal structure of aspartyl-tRNA synthetase from Pyrococcus kodakaraensis KOD: archaeon specificity and catalytic mechanism of adenylate formation. EMBO J (1998) 1.31
A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J (1997) 1.30
Conformational adaptation of agonists to the human nuclear receptor RAR gamma. Nat Struct Biol (1998) 1.29
The structure of an AspRS-tRNA(Asp) complex reveals a tRNA-dependent control mechanism. EMBO J (2001) 1.28
X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J (2001) 1.27
Recognition of tRNAs by aminoacyl-tRNA synthetases. FASEB J (1993) 1.27
Unusual helical packing in crystals of DNA bearing a mutation hot spot. Nature (1989) 1.26
Coordinated amino acid changes in homologous protein families. Protein Eng (1988) 1.24
Conformational changes and dynamics of tRNAs: evidence from hydrolysis patterns. Cold Spring Harb Symp Quant Biol (1987) 1.23
Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif. EMBO J (1996) 1.22
The first step of aminoacylation at the atomic level in histidyl-tRNA synthetase. Proc Natl Acad Sci U S A (1997) 1.21
Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci U S A (2001) 1.20
Three-dimensional structure of D-glyceraldehyde-3-phosphate dehydrogenase. J Mol Biol (1974) 1.19
Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett (2000) 1.17
Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem (2000) 1.16
Sequence, overproduction and crystallization of aspartyl-tRNA synthetase from Thermus thermophilus. Implications for the structure of prokaryotic aspartyl-tRNA synthetases. FEBS Lett (1993) 1.16
Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. J Mol Biol (2000) 1.16
Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects. J Biol Chem (2000) 1.15
Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism. J Biol Chem (2001) 1.15
Glycyl-tRNA synthetase uses a negatively charged pit for specific recognition and activation of glycine. J Mol Biol (1999) 1.15
Overexpression, purification, and crystal structure of native ER alpha LBD. Protein Expr Purif (2001) 1.14
A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 1.12
Role of dimerization in yeast aspartyl-tRNA synthetase and importance of the class II invariant proline. Proc Natl Acad Sci U S A (1993) 1.12
Dissecting the interaction network of multiprotein complexes by pairwise coexpression of subunits in E. coli. J Mol Biol (2001) 1.12
Groove-backbone interaction in B-DNA. Implication for DNA condensation and recombination. J Mol Biol (1991) 1.11
Crystal structure of a prokaryotic aspartyl tRNA-synthetase. EMBO J (1994) 1.11
Anticodon-anticodon interaction induces conformational changes in tRNA: yeast tRNAAsp, a model for tRNA-mRNA recognition. Proc Natl Acad Sci U S A (1986) 1.11
Solvation of the left-handed hexamer d(5BrC-G-5BrC-G-5 BrC-G) in crystals grown at two temperatures. J Mol Biol (1986) 1.10
Self-fitting and self-modifying properties of the B-DNA molecule. J Mol Biol (1995) 1.10
Retinoic acid receptor: a simulation analysis of retinoic acid binding and the resulting conformational changes. J Mol Biol (1999) 1.10
The contacts of yeast tRNA(Ser) with seryl-tRNA synthetase studied by footprinting experiments. Eur J Biochem (1990) 1.10
Synthesis and recognition of aspartyl-adenylate by Thermus thermophilus aspartyl-tRNA synthetase. J Mol Biol (1994) 1.10
A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. Structure (1997) 1.10
High resolution structure of the RNA duplex [U(U-A)6A]2. Nature (1988) 1.09
The structure of the Aeromonas proteolytica aminopeptidase complexed with a hydroxamate inhibitor. Involvement in catalysis of Glu151 and two zinc ions of the co-catalytic unit. Eur J Biochem (1996) 1.09